Stock Analiz

Globus Medical Inc. (GMED) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026

Summary

Globus Medical’s revenue went from $564M in fiscal 2016 to $2.9B in fiscal 2025, growth of about 20.1% a year.

Net income in fiscal 2025 was $538M, a net margin of 18.3%; the highest of the period.

Over the twelve months to September 30, 2026, revenue was $3.1B and net income $558M.

Free cash flow was $589M in fiscal 2025 and positive in 10 of the 10 years shown.

The diluted share count rose 42% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2016: $564M162017: $636M172018: $713M182019: $785M192020: $789M202021: $958M212022: $1.0B222023: $1.6B232024: $2.5B242025: $2.9B25$2.9B
Net income
2016: $104M162017: $107M172018: $156M182019: $155M192020: $102M202021: $149M212022: $190M222023: $123M232024: $103M242025: $538M25$538M
Free cash flow
2016: $107M162017: $108M172018: $122M182019: $101M192020: $135M202021: $219M212022: $104M222023: $165M232024: $405M242025: $589M25$589M
EPS (diluted)
2016: $1.08162017: $1.10172018: $1.54182019: $1.52192020: $1.01202021: $1.44212022: $1.85222023: $1.07232024: $0.75242025: $3.9225$3.92

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$3.1B$2.9B$2.5B$1.6B$1.0B$958M$789M$785M$713M$636M$564M
Gross profit$2.2B$2.0B$1.5B$1.0B$759M$719M$572M$605M$554M$486M$429M
Operating income$680M$480M$166M$133M$228M$172M$111M$172M$169M$162M$154M
Net income$558M$538M$103M$123M$190M$149M$102M$155M$156M$107M$104M
EPS (diluted)$4.06$3.92$0.75$1.07$1.85$1.44$1.01$1.52$1.54$1.10$1.08
R&D$144M$147M$164M$124M$73M$97M$85M$60M$55M$44M$45M
Revenue growth—+16.7%+60.6%+53.3%+6.8%+21.4%+0.5%+10.2%+12.1%+12.8%+3.5%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$926M$753M$521M$243M$178M$276M$199M$172M$182M$159M$148M
Capital spending-$159M-$165M-$115M-$78M-$74M-$57M-$64M-$71M-$60M-$51M-$41M
Free cash flow$767M$589M$405M$165M$104M$219M$135M$101M$122M$108M$107M
Dividends paid—$0$0$0$0$0$0$0$0$0$0
Buybacks$324M$300M$86M$226M$144M—$105M————
Stock-based pay$49M$50M$54M$53M$33M$31M$27M$26M$22M$15M$11M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$557M$890M$518M$446M$443M$427M$311M$340M$119M$67M
Debt—$119M$94M$520M$6M$5M$5M$2M———
Equity—$4.6B$4.2B$4.0B$1.8B$1.7B$1.5B$1.4B$1.2B$968M$832M
Total assets—$5.3B$5.3B$5.1B$2.1B$2.0B$1.7B$1.5B$1.3B$1.1B$928M
Shares (diluted)136M137M138M115M103M104M101M102M101M98M96M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin69.1%67.4%58.9%65.0%74.2%75.0%72.4%77.1%77.6%76.3%76.1%
Operating margin21.6%16.3%6.6%8.5%22.3%17.9%14.1%21.9%23.8%25.4%27.3%
Net margin17.8%18.3%4.1%7.8%18.6%15.6%13.0%19.8%21.9%16.9%18.5%
FCF margin24.4%20.0%16.1%10.5%10.2%22.9%17.1%12.9%17.1%16.9%19.0%
ROIC—9.1%3.3%2.2%9.6%8.1%6.0%10.0%11.8%10.6%12.3%
ROE—11.8%2.5%3.1%10.3%8.6%6.8%11.1%13.2%11.1%12.5%

Frequently asked questions

What is Globus Medical’s annual revenue?

$2.9B in fiscal 2025 and $3.1B over the twelve months to September 30, 2026.

How much profit does Globus Medical make?

Net income was $538M in fiscal 2025 (net margin 18.3%).

Is Globus Medical’s revenue growing?

Yes: revenue rose 16.7% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.